Alx Oncology Holdings (ALXO) Change in Acquisitions & Divestments (2022 - 2026)

Alx Oncology Holdings (ALXO) has 5 years of Change in Acquisitions & Divestments data on file, last reported at $19.5 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 55.15% year-over-year to $19.5 million; the trailing twelve-month figure through Mar 2026 stood at $110.4 million (down 38.55% YoY), and the FY2025 full-year result was $134.4 million, down 30.77% from the prior year.
• Change in Acquisitions & Divestments grew to $19.5 million in Q1 2026, from $17.3 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $115.2 million in Q1 2023 to a low of $17.3 million in Q4 2025.
• A 5-year average of $50.9 million and a median of $50.5 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments gained 27.53% in 2023 and plunged 55.15% in 2026, its largest moves.
• Tracing ALXO's Change in Acquisitions & Divestments over 5 years: stood at $72.3 million in 2022, then fell by 19.1% to $58.5 million in 2023, then slumped by 35.57% to $37.7 million in 2024, then tumbled by 54.21% to $17.3 million in 2025, then climbed by 13.0% to $19.5 million in 2026.
• Business Quant data shows ALXO's Change in Acquisitions & Divestments at $19.5 million in Q1 2026, $17.3 million in Q4 2025, and $25.9 million in Q3 2025.